Biosensors International
Singapore, Singapore· Est.
Global medical device company developing innovative drug-eluting stents and balloon catheters for cardiovascular interventions.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Global medical device company developing innovative drug-eluting stents and balloon catheters for cardiovascular interventions.
Cardiovascular
Technology Platform
Polymer-free drug-eluting stent technology utilizing biodegradable polymer coatings with abluminal drug release (primarily Biolimus A9) for coronary and peripheral vascular interventions.
Opportunities
Expansion into peripheral vascular interventions and drug-coated balloon markets, leveraging polymer-free technology platform for next-generation devices in competitive interventional cardiology space.
Risk Factors
Intense competition from larger medical device companies, pricing pressures in coronary stent markets, and technological disruption from bioresorbable scaffolds and alternative revascularization approaches.
Competitive Landscape
Competes against Abbott Vascular (Xience), Boston Scientific (Synergy), and Medtronic (Resolute) in drug-eluting stent market; differentiation through polymer-free technology and abluminal drug release targeting improved vessel healing.